BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33632664)

  • 1. Role of dual-point 18F-FDG-PET/CT in the diagnosis of pancreatic adenocarcinoma, in patients with and without concomitant chronic pancreatitis: Comparison with CECT and EUS.
    Kumar R; Sharma A; Garg P; Sharma R; Datta-Gupta S
    Pancreatology; 2021 Jun; 21(4):746-754. PubMed ID: 33632664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma.
    Rayamajhi S; Balachandran A; Katz M; Reddy A; Rohren E; Bhosale P
    Abdom Radiol (NY); 2018 Feb; 43(2):505-513. PubMed ID: 28900703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparison of (4S)-4-(3-
    Cheng MF; Huang YY; Ho BY; Kuo TC; Hsin LW; Shiue CY; Kuo HC; Jeng YM; Yen RF; Tien YW
    Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):810-820. PubMed ID: 30635754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
    Delbeke D; Rose DM; Chapman WC; Pinson CW; Wright JK; Beauchamp RD; Shyr Y; Leach SD
    J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorodeoxyglucose-positron emission tomography/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the initial staging of pancreatic adenocarcinoma.
    Santhosh S; Mittal BR; Bhasin DK; Rana SS; Gupta R; Das A; Nada R
    Ann Nucl Med; 2017 Oct; 31(8):575-581. PubMed ID: 28689356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of endoscopic ultrasound guided fine needle aspiration and PET/CT in preoperative diagnosis of pancreatic adenocarcinoma.
    Lai JP; Yue Y; Zhang W; Zhou Y; Frishberg D; Jamil LH; Mirocha JM; Guindi M; Balzer B; Bose S; Cao D; Lo S; Fan X; Rutgers JK
    Pancreatology; 2017; 17(4):617-622. PubMed ID: 28501471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: a meta-analysis.
    Tang S; Huang G; Liu J; Liu T; Treven L; Song S; Zhang C; Pan L; Zhang T
    Eur J Radiol; 2011 Apr; 78(1):142-50. PubMed ID: 19854016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-neoadjuvant treatment pancreatic cancer resectability and outcome prediction using CT,
    Yoo J; Lee JM; Joo I; Lee DH; Yoon JH; Yu MH; Jang JY; Lee SH
    Cancer Imaging; 2023 May; 23(1):49. PubMed ID: 37217958
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Su W; Zhao S; Chen Y; Zuo C; Cui B; Wang M; Ren F
    Abdom Radiol (NY); 2020 Mar; 45(3):743-749. PubMed ID: 31907569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
    Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
    Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics model of dual-time 2-[
    Liu Z; Li M; Zuo C; Yang Z; Yang X; Ren S; Peng Y; Sun G; Shen J; Cheng C; Yang X
    Eur Radiol; 2021 Sep; 31(9):6983-6991. PubMed ID: 33677645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT Metabolic Tumor Volume and Intratumoral Heterogeneity in Pancreatic Adenocarcinomas: Impact of Dual-Time Point and Segmentation Methods.
    Mena E; Sheikhbahaei S; Taghipour M; Jha AK; Vicente E; Xiao J; Subramaniam RM
    Clin Nucl Med; 2017 Jan; 42(1):e16-e21. PubMed ID: 27819858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
    Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
    Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of EUS-FNA for preoperative para-aortic lymph node staging in patients with pancreatobiliary cancer.
    Kurita A; Kodama Y; Nakamoto Y; Isoda H; Minamiguchi S; Yoshimura K; Kuriyama K; Sawai Y; Uza N; Hatano E; Uemoto S; Togashi K; Haga H; Chiba T
    Gastrointest Endosc; 2016 Sep; 84(3):467-475.e1. PubMed ID: 26970011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of 18F-FDG PET/CT combined with carbohydrate antigen 19-9 for differentiating pancreatic carcinoma from chronic mass-forming pancreatitis in Chinese elderly.
    Gu X; Liu R
    Clin Interv Aging; 2016; 11():1365-1370. PubMed ID: 27729779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy.
    Hildebrandt MG; Gerke O; Baun C; Falch K; Hansen JA; Farahani ZA; Petersen H; Larsen LB; Duvnjak S; Buskevica I; Bektas S; Søe K; Jylling AM; Ewertz M; Alavi A; Høilund-Carlsen PF
    J Clin Oncol; 2016 Jun; 34(16):1889-97. PubMed ID: 27001573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.
    Yeh R; Dercle L; Garg I; Wang ZJ; Hough DM; Goenka AH
    Abdom Radiol (NY); 2018 Feb; 43(2):415-434. PubMed ID: 29143875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
    Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
    J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?
    Perlaza P; Ortín J; Pagès M; Buxó E; Fernández-Esparrach G; Colletti PM; Rubello D; Mayoral M; Sánchez N; Ruiz C; Ginés A; Fuster D
    Clin Nucl Med; 2018 Jun; 43(6):402-410. PubMed ID: 29485442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified dual time point FDG-PET/computed tomography for determining dignity of pancreatic lesions.
    Bieg C; Mongelli F; Peterli R; Chirindel AF; Metzger J; von Flüe M; Gass M
    Nucl Med Commun; 2020 Jul; 41(7):682-687. PubMed ID: 32404649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.